在宅尿検査市場：製品タイプ、技術、採取方法、製品形態、流通チャネル、用途別-2025-2030年世界予測

在宅尿検査市場は、2024年には13億8,000万米ドルとなり、2025年には14億9,000万米ドル、CAGR 8.47%で成長し、2030年には22億5,000万米ドルに達すると予測されています。

近年、ヘルスケア業界では診断プロセスの分散化が顕著になり、在宅尿検査が患者のケア管理に不可欠な要素となっています。このイントロダクションでは、進化する状況を徹底的に調査し、在宅検査に内在する利点と課題を包括的に紹介します。技術革新は、検査手順のスピードと精度を向上させただけでなく、遠隔モニタリングと早期診断のためのツールを提供することで、患者と専門家に力を与えています。

同市場は、技術の高度化と相まって、消費者の認識と受容の急速な高まりを目の当たりにしています。消費者は、その利便性、迅速な結果、従来のヘルスケア施設の負担を軽減する可能性から、ますますこれらの検査に注目するようになっています。さらに、在宅検査ソリューションは、デジタルヘルスツールの進歩と接続性の向上により飛躍的な成長を遂げ、データ主導の意思決定と個別化ケアが絡み合うエコシステムを育んでいます。ヘルスケア診断業界のこの分野は、健康アウトカムの改善、コスト効率の向上、患者エンゲージメントの強化への要望によって形を変え続けています。

利用しやすい健康モニタリングへの需要が高まるにつれ、業界各社は革新的な製品を開発し、提供する必要性に迫られています。このような背景から、本レポートでは、持続可能な成長と患者の転帰の改善を視野に入れながら、在宅尿検査市場の促進要因・課題・将来の機会を検証します。

在宅尿検査市場の変革

在宅尿検査市場は、ヘルスケア診断における役割を再定義する変革期を迎えています。デジタル革命によって加速された消費者行動の変化は、検査の受け止め方と利用方法を根本的に変えました。遠隔患者モニタリングと遠隔医療サービスの急増は、この変化を促進する重要なきっかけとなりました。

最も大きな変化のひとつは、検査結果の精度とアクセシビリティを高めるデジタルソリューションの統合です。デジタル尿検査器は現在、モバイル・アプリケーションとのシームレスな接続を提供し、ユーザーが長期にわたって健康パラメーターを追跡できるようにし、ヘルスケア専門家がタイムリーな介入を行えるようにしています。より相互接続されたデータ中心のアプローチへのこのシフトは、診断の精度を向上させただけでなく、患者のニーズに対するポジションがはるかにダイナミックになり、対応できるようになりました。

もうひとつの注目すべき変化は、利便性とプライバシーを重視する消費者の増加にあります。在宅検査は、結果の信頼性を損なうことなく、慎重さと使いやすさを提供するため、従来の診察に代わるものとして、個人は在宅検査を選ぶようになっています。さらに、規制当局もガイドラインを合理化し、監視を強化することで、こうした進歩を認識し、適応しており、市場の信頼を強化しています。このような変化の積み重ねが、ダイナミックで応答性の高い検査環境を生み出し、絶え間ないイノベーションがヘルスケアプロバイダーと患者双方の進化する要求に応えています。

在宅尿検査における主要セグメント分析

市場情勢を詳細なセグメンテーションレンズで分析すると、在宅尿検査市場の多面的な性質が明らかになります。製品タイプに基づくセグメンテーションにより、尿検査市場は、採尿デバイス、尿検査キット、尿検査ストリップなど、いくつかの主要カテゴリーにわたって調査されていることが明らかになりました。さらに、尿検査用ストリップ自体が、特に薬物検査用ストリップ、グルコース検査用ストリップ、ケトン検査用ストリップ、pH検査用ストリップ、妊娠検査用ストリップ、タンパク質検査用ストリップなどのバリエーションにわたって、詳細な調査の対象になっていることが示されています。この詳細な分類により、市場全体の製品の多様性と技術革新に関する洞察が得られます。

技術的な観点から見ると、生物分析センサー、比色分析に基づく検査、デジタル尿検査器、酵素結合免疫吸着測定法（ELISA）、イムノクロマトグラフィー測定法（ラテラルフロー）などの方法を用いて市場を分析しています。それぞれの技術的アプローチは、検査結果の正確さ、スピード、全体的な有効性を決定する上で極めて重要な役割を果たしています。例えば、デジタル尿検査装置は最新の接続性と分析を活用し、比色分析に基づく方法は検査結果の信頼性が高く、わかりやすい解釈を提供します。

採尿方法に基づくセグメンテーションでは、プロセスを朝一採尿、中間採尿、定時採尿に分けることで、市場動向をさらに解明しています。これらの方法はそれぞれ独自の利点を提供し、明確な臨床ニーズに対応することで、市場全体のニュアンスを高めています。さらに、製品形態によるセグメンテーションでは、製品をマルチユースとシングルユースのプラットフォームに分類することで、効率性とユーザーの利便性のトレードオフを明確にしています。流通チャネル分析ではさらに、市場をオフラインとオンラインのカテゴリーに区別し、オフラインチャネルは薬局とスーパーマーケット、オンラインチャネルは企業のウェブストアとサードパーティーマーケットプレースを代表とします。

最後に、アプリケーションベースのセグメンテーションは、在宅尿検査の包括的な使用事例を強調しています。この市場は、糖尿病モニタリング、薬物・アルコール検査、腎機能モニタリング、肥満・ケトーシスモニタリングのニーズを満たすだけでなく、薬局・ウェルネスモニタリング、妊娠検査、尿路感染症（UTI）検査にも対応しています。この微妙なセグメンテーション・アプローチにより、利害関係者は特定の成長分野を特定し、ヘルスケア消費者の多様な需要に対応する戦略を策定することができ、イノベーションが患者中心の成果に体系的に合致するようになります。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 個人の健康モニタリングと予防ヘルスケアに対する消費者の関心の高まり
    • 定期的なモニタリングを必要とする慢性疾患や生活習慣病の罹患率の上昇
    • 精度とテストの容易さを向上させるための研究開発への投資の増加
  • 抑制要因
    • 実験室での検査に比べて精度が低い
  • 機会
    • 個人が費用対効果の高いソリューションを求めるにつれて、DIY健康診断に対する消費者の需要が高まっている
    • デジタルヘルスプラットフォームと尿検査の統合を可能にする技術の進歩
  • 課題
    • データのプライバシーと個人の健康情報のセキュリティに関する懸念
• 市場セグメンテーション分析
  • 製品タイプ：特定の健康モニタリングニーズに対応する尿検査キットの採用増加
  • 用途：薬物やアルコールの摂取を監視するための自宅での尿検査の応用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 在宅尿検査市場：製品タイプ別

• 尿収集装置
• 尿検査キット
• 尿検査ストリップ
  • 薬物検査ストリップ
  • グルコーステストストリップ
  • ケトン検査ストリップ
  • pHテストストリップ
  • 妊娠検査薬
  • タンパク質検査ストリップ

第7章 在宅尿検査市場：技術別

• バイオ分析センサー
• 比色法によるテスト
• デジタル尿検査装置
• 酵素免疫測定法（ELISA）
• 免疫クロマトグラフィーアッセイ（ラテラルフロー）

第8章 在宅尿検査市場収集方法別

• 朝一番の尿
• 中間尿採取
• 時間指定尿採取

第9章 在宅尿検査市場：製品形態別

• 多用途
• 使い捨て

第10章 在宅尿検査市場：流通チャネル別

• オフライン
  • 薬局
  • スーパーマーケット
• オンライン
  • 企業ウェブストア
  • サードパーティマーケットプレイス

第11章 在宅尿検査市場：用途別

• 糖尿病モニタリング
• 薬物・アルコール検査
• 腎機能モニタリング
• 肥満とケトーシスのモニタリング
• 薬局と健康モニタリング
• 妊娠検査
• 尿路感染症（UTI）検査

第12章 南北アメリカの在宅尿検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の在宅尿検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの在宅尿検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• ACON Laboratories, Inc.
• AdvaCare Pharma
• AlphaBiolabs Ltd.
• AZO Products
• Church & Dwight Co., Inc.
• Clinical Guard
• Easy Healthcare Corporation
• Equinox Biotech Co., Ltd.
• Everlywell, Inc.
• Laboratory Corporation of America Holdings
• LIFE2O
• Mankind Pharma Limited
• Medline Industries, Inc.
• MomMed
• myLAB Box
• PREGMATE
• Quest Diagnostics Incorporated
• Roman Health Ventures Inc.
• Siemens Healthineers AG
• SPD Swiss Precision Diagnostics GmbH
• Target Brands, Inc.
• Trividia Health, Inc.
• Viatris Inc.
• Walgreens Boots Alliance, Inc.
• Walmart Inc.
• Winx Health, Inc.
• ZRT Laboratory LLC

LIST OF FIGURES

• FIGURE 1. AT-HOME URINE TESTING MARKET MULTI-CURRENCY
• FIGURE 2. AT-HOME URINE TESTING MARKET MULTI-LANGUAGE
• FIGURE 3. AT-HOME URINE TESTING MARKET RESEARCH PROCESS
• FIGURE 4. AT-HOME URINE TESTING MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL AT-HOME URINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 23. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. AT-HOME URINE TESTING MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 29. AT-HOME URINE TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. AT-HOME URINE TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL AT-HOME URINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AT-HOME URINE TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY URINE COLLECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY DRUG TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY GLUCOSE TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY KETONE TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PH TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PREGNANCY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PROTEIN TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY BIOANALYTICAL SENSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY COLORIMETRY-BASED TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY DIGITAL URINE TESTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC ASSAY (LATERAL FLOW), BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY FIRST-MORNING URINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY MIDSTREAM URINE COLLECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY TIMED URINE COLLECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY MULTI-USE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY COMPANY WEBSTORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY DIABETES MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY DRUG & ALCOHOL TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY KIDNEY FUNCTION MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY OBESITY & KETOSIS MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PHARMACY & WELLNESS MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY PREGNANCY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL AT-HOME URINE TESTING MARKET SIZE, BY URINARY TRACT INFECTION (UTI) TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 75. BRAZIL AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. CANADA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. CANADA AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 78. CANADA AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. CANADA AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 80. CANADA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 81. CANADA AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. CANADA AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 83. CANADA AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 84. CANADA AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 92. MEXICO AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 93. MEXICO AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 102. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. UNITED STATES AT-HOME URINE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 112. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. AUSTRALIA AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 118. AUSTRALIA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 119. AUSTRALIA AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. AUSTRALIA AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 121. AUSTRALIA AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 122. AUSTRALIA AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. CHINA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. CHINA AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 125. CHINA AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. CHINA AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 127. CHINA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 128. CHINA AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. CHINA AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 130. CHINA AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 131. CHINA AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. INDIA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. INDIA AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 134. INDIA AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. INDIA AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 136. INDIA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 137. INDIA AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. INDIA AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 139. INDIA AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 140. INDIA AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. INDONESIA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. INDONESIA AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 143. INDONESIA AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. INDONESIA AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 145. INDONESIA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 146. INDONESIA AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. INDONESIA AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 148. INDONESIA AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 149. INDONESIA AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. JAPAN AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. JAPAN AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 152. JAPAN AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. JAPAN AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 154. JAPAN AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 155. JAPAN AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. JAPAN AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 157. JAPAN AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 158. JAPAN AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. MALAYSIA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 160. MALAYSIA AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 161. MALAYSIA AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. MALAYSIA AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 163. MALAYSIA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 164. MALAYSIA AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. MALAYSIA AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 166. MALAYSIA AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 167. MALAYSIA AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. PHILIPPINES AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 169. PHILIPPINES AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 170. PHILIPPINES AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. PHILIPPINES AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 172. PHILIPPINES AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 173. PHILIPPINES AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. PHILIPPINES AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 175. PHILIPPINES AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 176. PHILIPPINES AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SINGAPORE AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SINGAPORE AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 179. SINGAPORE AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. SINGAPORE AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 181. SINGAPORE AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 182. SINGAPORE AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 183. SINGAPORE AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 184. SINGAPORE AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 185. SINGAPORE AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. SOUTH KOREA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 187. SOUTH KOREA AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 188. SOUTH KOREA AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. SOUTH KOREA AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 190. SOUTH KOREA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 191. SOUTH KOREA AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 192. SOUTH KOREA AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 193. SOUTH KOREA AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 194. SOUTH KOREA AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. TAIWAN AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 196. TAIWAN AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 197. TAIWAN AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. TAIWAN AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 199. TAIWAN AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 200. TAIWAN AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 201. TAIWAN AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 202. TAIWAN AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 203. TAIWAN AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. THAILAND AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 205. THAILAND AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 206. THAILAND AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. THAILAND AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 208. THAILAND AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 209. THAILAND AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 210. THAILAND AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 211. THAILAND AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 212. THAILAND AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. VIETNAM AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. VIETNAM AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 215. VIETNAM AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 216. VIETNAM AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 217. VIETNAM AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 218. VIETNAM AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 219. VIETNAM AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 220. VIETNAM AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 221. VIETNAM AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 228. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 229. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 230. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. EUROPE, MIDDLE EAST & AFRICA AT-HOME URINE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 232. DENMARK AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 233. DENMARK AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 234. DENMARK AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. DENMARK AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 236. DENMARK AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 237. DENMARK AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 238. DENMARK AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 239. DENMARK AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 240. DENMARK AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. EGYPT AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 242. EGYPT AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 243. EGYPT AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 244. EGYPT AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 245. EGYPT AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 246. EGYPT AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 247. EGYPT AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 248. EGYPT AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 249. EGYPT AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. FINLAND AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 251. FINLAND AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 252. FINLAND AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 253. FINLAND AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 254. FINLAND AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 255. FINLAND AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 256. FINLAND AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 257. FINLAND AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 258. FINLAND AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. FRANCE AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 260. FRANCE AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 261. FRANCE AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 262. FRANCE AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 263. FRANCE AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 264. FRANCE AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 265. FRANCE AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 266. FRANCE AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 267. FRANCE AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. GERMANY AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 269. GERMANY AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 270. GERMANY AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 271. GERMANY AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 272. GERMANY AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 273. GERMANY AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 274. GERMANY AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 275. GERMANY AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 276. GERMANY AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. ISRAEL AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 278. ISRAEL AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 279. ISRAEL AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 280. ISRAEL AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 281. ISRAEL AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 282. ISRAEL AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 283. ISRAEL AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 284. ISRAEL AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 285. ISRAEL AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 286. ITALY AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 287. ITALY AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 288. ITALY AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 289. ITALY AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 290. ITALY AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 291. ITALY AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 292. ITALY AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 293. ITALY AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 294. ITALY AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 295. NETHERLANDS AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 296. NETHERLANDS AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 297. NETHERLANDS AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 298. NETHERLANDS AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 299. NETHERLANDS AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 300. NETHERLANDS AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 301. NETHERLANDS AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 302. NETHERLANDS AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 303. NETHERLANDS AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 304. NIGERIA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 305. NIGERIA AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 306. NIGERIA AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 307. NIGERIA AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 308. NIGERIA AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 309. NIGERIA AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 310. NIGERIA AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 311. NIGERIA AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 312. NIGERIA AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 313. NORWAY AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 314. NORWAY AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 315. NORWAY AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 316. NORWAY AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 317. NORWAY AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 318. NORWAY AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 319. NORWAY AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 320. NORWAY AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 321. NORWAY AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 322. POLAND AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 323. POLAND AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 324. POLAND AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 325. POLAND AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 326. POLAND AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 327. POLAND AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 328. POLAND AT-HOME URINE TESTING MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 329. POLAND AT-HOME URINE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
• TABLE 330. POLAND AT-HOME URINE TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 331. QATAR AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 332. QATAR AT-HOME URINE TESTING MARKET SIZE, BY URINE TEST STRIPS, 2018-2030 (USD MILLION)
• TABLE 333. QATAR AT-HOME URINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 334. QATAR AT-HOME URINE TESTING MARKET SIZE, BY COLLECTION METHOD, 2018-2030 (USD MILLION)
• TABLE 335. QATAR AT-HOME URINE TESTING MARKET SIZE, BY PRODUCT FORM, 2018-2030 (USD MILLION)
• TABLE 336. QATAR AT-HOME URINE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 337. QATAR AT-HOME URINE TESTING MAR

The At-Home Urine Testing Market was valued at USD 1.38 billion in 2024 and is projected to grow to USD 1.49 billion in 2025, with a CAGR of 8.47%, reaching USD 2.25 billion by 2030.

In recent years, the healthcare industry has witnessed a pronounced shift towards decentralization of diagnostic processes, with at-home urine testing emerging as a critical component in patient care management. This introduction sets the stage for a thorough exploration of the evolving landscape, presenting a comprehensive overview of the advantages and challenges inherent in at-home testing. Technological innovations have not only enhanced the speed and accuracy of testing procedures but have also empowered patients and professionals by providing tools for remote monitoring and early diagnosis.

The market is witnessing a rapid increase in consumer awareness and acceptance coupled with rising technological sophistication. Consumers are increasingly turning towards these tests for their convenience, rapid results, and potential to alleviate the burden on traditional healthcare facilities. Moreover, at-home testing solutions have seen exponential growth spurred by advancements in digital health tools and improved connectivity, fostering an ecosystem where data-driven decision making and personalized care intertwine. This segment of the healthcare diagnostic industry continues to be reshaped by the desire for improved health outcomes, cost efficiencies, and enhanced patient engagement.

As the demand for accessible health monitoring grows, industry players are compelled to innovate and expand their offerings. In this context, the report examines the drivers, challenges, and future opportunities in the at-home urine testing market with an eye toward sustainable growth and improved patient outcomes.

Transformative Shifts in the Urine Testing Landscape

The at-home urine testing market has undergone transformative shifts that have redefined its role in healthcare diagnostics. Changes in consumer behavior, accelerated by the digital revolution, have fundamentally altered how tests are perceived and utilized. The surge in remote patient monitoring and telemedicine services has been a key catalyst in driving this shift.

One of the most significant changes has been the integration of digital solutions that enhance the precision and accessibility of test results. Digital urine testers now offer seamless connectivity with mobile applications, allowing users to track health parameters over time and enabling healthcare professionals to provide timely interventions. This shift towards a more interconnected and data-centric approach has not only improved the accuracy of diagnoses but has also ensured that positions are now far more dynamic and responsive to patient needs.

Another noteworthy transformation lies in the increased consumer emphasis on convenience and privacy. Individuals are opting for at-home tests as a preferred alternative to traditional clinical visits because they offer discretion and ease of use without compromising the reliability of results. Additionally, regulatory bodies have recognized and adapted to these advancements by streamlining guidelines and enhancing oversight, thereby reinforcing market confidence. The cumulative impact of these changes is a dynamic and responsive testing landscape, where continuous innovation meets the evolving demands of both healthcare providers and patients.

Key Segmentation Insights in At-Home Urine Testing

Analyzing the landscape through a detailed segmentation lens reveals the multifaceted nature of the at-home urine testing market. The segmentation based on product type reveals that the market is studied across several key categories including urine collection devices, urine test kits, and urine test strips. The segmentation further indicates that urine test strips themselves are subject to detailed study, particularly across variations such as drug test strips, glucose test strips, ketone test strips, pH test strips, pregnancy test strips, and protein test strips. This detailed categorization provides insights into product diversity and technological innovation across the market.

When viewed from a technological perspective, the market is analyzed using methods that include bioanalytical sensors, colorimetry-based testing, digital urine testers, enzyme-linked immunosorbent assay (ELISA), and immunochromatographic assay (lateral flow). Each technological approach plays a pivotal role in determining the accuracy, speed, and overall effectiveness of test results. For example, digital urine testers leverage modern connectivity and analytics, while colorimetry-based methods provide a reliable and straightforward interpretation of test outcomes.

The segmentation based on collection methods further elucidates market trends by dividing the process into first-morning urine, midstream urine collection, and timed urine collection. Each of these methods offers unique advantages and caters to distinct clinical needs, thereby enhancing the overall market nuance. Additionally, segmentation by product form characterizes the offerings into multi-use and single-use platforms, thereby underlining the trade-offs between efficiency and user convenience. Distribution channel analysis further distinguishes the market into offline and online categories, with offline channels being represented through pharmacies and supermarkets, and online channels featuring company webstores and third party marketplaces.

Lastly, the application-based segmentation underscores the comprehensive use cases for at-home urine testing. The market not only meets the needs for diabetes monitoring, drug and alcohol testing, kidney function monitoring, and obesity and ketosis monitoring but also extends support for pharmacy and wellness monitoring, pregnancy testing, and urinary tract infection (UTI) testing. This nuanced segmentation approach allows stakeholders to identify specific growth areas and formulate strategies that address the varied demands of healthcare consumers, ensuring that innovations are systematically aligned with patient-centric outcomes.

Based on Product Type, market is studied across Urine Collection Devices, Urine Test Kits, and Urine Test Strips. The Urine Test Strips is further studied across Drug Test Strips, Glucose Test Strips, Ketone Test Strips, pH Test Strips, Pregnancy Test Strips, and Protein Test Strips.

Based on Technology, market is studied across Bioanalytical Sensors, Colorimetry-Based Testing, Digital Urine Testers, Enzyme-Linked Immunosorbent Assay (ELISA), and Immunochromatographic Assay (Lateral Flow).

Based on Collection Method, market is studied across First-morning Urine, Midstream Urine Collection, and Timed Urine Collection.

Based on Product Form, market is studied across Multi-use and Single-use.

Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Pharmacies and Supermarkets. The Online is further studied across Company Webstores and Third Party Marketplaces.

Based on Application, market is studied across Diabetes Monitoring, Drug & Alcohol Testing, Kidney Function Monitoring, Obesity & Ketosis Monitoring, Pharmacy & Wellness Monitoring, Pregnancy Testing, and Urinary Tract Infection (UTI) Testing.

Key Regional Insights Driving Market Dynamics

A deep dive into regional insights provides an expansive view of how geographic diversities are shaping the at-home urine testing market. In the Americas, widespread adoption of advanced diagnostic tools is reported alongside a robust infrastructure that continues to support technological participation in remote healthcare. The region benefits from strong public health initiatives and a network of research institutions that actively contribute to the evolution of at-home testing solutions.

In the Europe, Middle East & Africa markets, there is a noticeable trend towards stringent regulatory compliance and an emphasis on high-quality diagnostic outcomes. This region prioritizes patient safety by ensuring that the latest innovations in at-home testing are adopted responsibly. Culturally sensitive approaches to healthcare delivery in these areas also promote a balanced integration of traditional clinical practices with modern testing methodologies.

Turning attention to the Asia-Pacific region, the market is characterized by rapid economic growth, technological advancements, and an increasing focus on preventive healthcare. The high population density, combined with a growing demand for accessible healthcare solutions, has propelled the adoption of innovative testing methods. Overall, regional analysis paints a vivid picture where differentiated growth strategies are designed to address specific market needs, regulatory challenges, and consumer preferences across varied geographic landscapes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the At-Home Testing Innovation

A review of the leading companies in the at-home urine testing space reveals a diverse array of industry pioneers. Major players such as Abbott Laboratories and ACON Laboratories, Inc. act as drivers of innovation, continuously developing new formulations that expand the market's technical capabilities. Companies like AdvaCare Pharma and AlphaBiolabs Ltd. contribute by focusing on robust quality control and user-friendly product designs, ensuring that the tests are both reliable and accessible.

Key names including AZO Products and Church & Dwight Co., Inc. show how strong brand trust coupled with technological leadership can significantly influence market trends. Similarly, firms like Clinical Guard, Easy Healthcare Corporation, and Equinox Biotech Co., Ltd. have carved out niche segments where innovation meets efficiency. Everlywell, Inc. and Laboratory Corporation of America Holdings underscore the importance of integrating digital health tools with traditional analytics, highlighting a trend where remote testing solutions bridge the gap between clinical accuracy and consumer convenience.

Other noteworthy contributors include LIFE2O, Mankind Pharma Limited, and Medline Industries, Inc., whose efforts in enhancing product quality and usability have set benchmarks in the industry. The portfolio of companies is further diversified with the contributions of MomMed, myLAB Box, PREGMATE, Quest Diagnostics Incorporated, and Roman Health Ventures Inc., each emphasizing a tailored approach to testing based on user requirements. Siemens Healthineers AG and SPD Swiss Precision Diagnostics GmbH bring a technology-focused perspective to the market, while Target Brands, Inc., Trividia Health, Inc., Viatris Inc., Walgreens Boots Alliance, Inc., Walmart Inc., Winx Health, Inc., and ZRT Laboratory LLC equally showcase how distribution scale and market penetration can influence market dynamics. Collectively, these companies illustrate a competitive ecosystem where continuous innovation is key to meeting the demands of an evolving healthcare landscape.

The report delves into recent significant developments in the At-Home Urine Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., AdvaCare Pharma, AlphaBiolabs Ltd., AZO Products, Church & Dwight Co., Inc., Clinical Guard, Easy Healthcare Corporation, Equinox Biotech Co., Ltd., Everlywell, Inc., Laboratory Corporation of America Holdings, LIFE2O, Mankind Pharma Limited, Medline Industries, Inc., MomMed, myLAB Box, PREGMATE, Quest Diagnostics Incorporated, Roman Health Ventures Inc., Siemens Healthineers AG, SPD Swiss Precision Diagnostics GmbH, Target Brands, Inc., Trividia Health, Inc., Viatris Inc., Walgreens Boots Alliance, Inc., Walmart Inc., Winx Health, Inc., and ZRT Laboratory LLC. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to invest in emerging digital technologies that enhance the reliability and accessibility of at-home urine testing. Emphasizing strategic collaborations and research partnerships can accelerate product innovations, particularly in integrating bioanalytical sensors and digital connectivity with routine diagnostic processes. Companies should consider optimizing their product portfolios by balancing multi-use and single-use offerings, and leveraging both offline and online distribution channels. Future growth will be underpinned by the ability to tailor solutions for specific applications such as diabetes monitoring, kidney function, and early detection of health conditions. Continuous feedback mechanisms must be integrated into development cycles, ensuring that product quality and user satisfaction remain at the forefront of innovation.

Conclusion: Reflections on Market Trends and Opportunities

The dynamic evolution of at-home urine testing marks a significant milestone in modern healthcare diagnostics. As the market continues to embrace technological advancements and diversified segmentation strategies, stakeholders are provided with unprecedented opportunities to enhance patient engagement and clinical outcomes. The multi-layered segmentation based on product type, technological innovation, collection methods, product form, distribution channels, and varied applications underscores the potential of the market to drive sustained growth. Regional dynamics further emphasize how localized strategies can be harmonized with global trends to spearhead industry advancements. Ultimately, the sector's future success will hinge on the ability of industry pioneers to adeptly balance innovation with regulatory compliance and user-centric design.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased consumer interest in personal health monitoring and preventive healthcare
    • 5.1.1.2. Rising prevalence of chronic and lifestyle-related diseases necessitating regular monitoring
    • 5.1.1.3. Increased investment in research and development for enhanced accuracy and ease of testing
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of accuracy compared to laboratory testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing consumer demand for DIY health diagnostics as individuals seek cost-effective solutions
    • 5.1.3.2. Technological advancements enabling the integration of digital health platforms and urine testing
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns about data privacy and the security of personal health information
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Growing adoption of urine test kits for specific health monitoring needs
  • 5.2.2. Application: Rising application of at home urine testing in drug & alcohol testing to monitor substance intake
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. At-Home Urine Testing Market, by Product Type

• 6.1. Introduction
• 6.2. Urine Collection Devices
• 6.3. Urine Test Kits
• 6.4. Urine Test Strips
  • 6.4.1. Drug Test Strips
  • 6.4.2. Glucose Test Strips
  • 6.4.3. Ketone Test Strips
  • 6.4.4. pH Test Strips
  • 6.4.5. Pregnancy Test Strips
  • 6.4.6. Protein Test Strips

7. At-Home Urine Testing Market, by Technology

• 7.1. Introduction
• 7.2. Bioanalytical Sensors
• 7.3. Colorimetry-Based Testing
• 7.4. Digital Urine Testers
• 7.5. Enzyme-Linked Immunosorbent Assay (ELISA)
• 7.6. Immunochromatographic Assay (Lateral Flow)

8. At-Home Urine Testing Market, by Collection Method

• 8.1. Introduction
• 8.2. First-morning Urine
• 8.3. Midstream Urine Collection
• 8.4. Timed Urine Collection

9. At-Home Urine Testing Market, by Product Form

• 9.1. Introduction
• 9.2. Multi-use
• 9.3. Single-use

10. At-Home Urine Testing Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Offline
  • 10.2.1. Pharmacies
  • 10.2.2. Supermarkets
• 10.3. Online
  • 10.3.1. Company Webstores
  • 10.3.2. Third Party Marketplaces

11. At-Home Urine Testing Market, by Application

• 11.1. Introduction
• 11.2. Diabetes Monitoring
• 11.3. Drug & Alcohol Testing
• 11.4. Kidney Function Monitoring
• 11.5. Obesity & Ketosis Monitoring
• 11.6. Pharmacy & Wellness Monitoring
• 11.7. Pregnancy Testing
• 11.8. Urinary Tract Infection (UTI) Testing

12. Americas At-Home Urine Testing Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific At-Home Urine Testing Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa At-Home Urine Testing Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Pharmac funds at-home urine testing kits for post-abortion care
  • 15.3.2. Alpha Laboratories and Clinical Design Technologies form alliance to innovate urinalysis
  • 15.3.3. Toyoda Gosei invests in Yuurea for at-home urine testing innovation
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACON Laboratories, Inc.
• 3. AdvaCare Pharma
• 4. AlphaBiolabs Ltd.
• 5. AZO Products
• 6. Church & Dwight Co., Inc.
• 7. Clinical Guard
• 8. Easy Healthcare Corporation
• 9. Equinox Biotech Co., Ltd.
• 10. Everlywell, Inc.
• 11. Laboratory Corporation of America Holdings
• 12. LIFE2O
• 13. Mankind Pharma Limited
• 14. Medline Industries, Inc.
• 15. MomMed
• 16. myLAB Box
• 17. PREGMATE
• 18. Quest Diagnostics Incorporated
• 19. Roman Health Ventures Inc.
• 20. Siemens Healthineers AG
• 21. SPD Swiss Precision Diagnostics GmbH
• 22. Target Brands, Inc.
• 23. Trividia Health, Inc.
• 24. Viatris Inc.
• 25. Walgreens Boots Alliance, Inc.
• 26. Walmart Inc.
• 27. Winx Health, Inc.
• 28. ZRT Laboratory LLC